Helicobacter Pylori Test Market Future Insights, Share Value, COVID-19 Impact and Emerging Trends By 2027
Global
H. Pylori (Helicobacter Pylori) Test Market Research Report: By Test Type
(Non-Endoscopic, Endoscopic), By Technology (Immunoassays, Point-of-Care (POC),
Molecular Diagnostics) and By End-User (Hospitals and Clinics, Diagnostics
Laboratories, Others) – Forecast to 2027
Global H. Pylori (Helicobacter Pylori) Test
Market Highlights
According to MRFR analysis, H. Pylori (Helicobacter Pylori) Test Market
is expected to register a CAGR of 5.2% during the forecast period of 2019 to
2025 and is expected to reach USD 2,924.2 Million by 2025. Helicobacter pylori
infection occurs when the H. pylori bacteria infects the stomach. Some of the
major factors driving the market growth are the growing burden of H. pylori
infections and dyspepsia, availability of diagnostic tests, the presence of a
cost-effective diagnosis of H. pylori, and globally surging target patient
population. Dyspepsia is a condition associated with gastrointestinal (GI)
disease, with a worldwide prevalence of around 20%. H. pylori-associated
diseases are commonly present with dyspepsia. On the contrary, low diagnosis
rates of helicobacter pylori infection in developing nations is anticipated to
limit the market growth during the review period.
Regional
Analysis
The market has been divided by
region into the Americas, Europe, Asia-Pacific, and the Middle East &
Africa. The H. pylori test market in the Americas has further been segmented
into North America and Latin America, with the North American market segregated
into the US and Canada. The existence of prominent market players and advanced
healthcare infrastructure in the US and Canada is assisting the dominance of
the North American market. The European H. pylori test market has been
categorized as Western Europe and Eastern Europe. The Western European market
has further been classified as Germany, France, the UK, Italy, Spain, and the
rest of Western Europe. The H. pylori test market in Asia-Pacific has been
segmented into Japan, China, India, South Korea, Australia, and the rest of
Asia-Pacific. Asia-Pacific is likely to register the fastest market growth
during the forecast period owing to the presence of target population base,
growing awareness about H. pylori and its diagnosis, and increasing per capita
health expenditure in India, China, and Japan.
The H. pylori test market in
the Middle East & Africa has been bifurcated into the Middle East and
Africa.
Request
Free Sample Copy at:
https://www.marketresearchfuture.com/sample_request/8497
Segmentation
The Global H. Pylori Test
Market has been segmented based on test type, technology, and end-user.
Based on the test type, the
market has been divided into non-endoscopic and endoscopic. The non-endoscopic
segment has been further classified as stool/fecal antigen test (SAT), urea
breath test (UBT), and serology/antibody/blood test. The endoscopic segment is
additionally categorized into culture, histology, rapid
urease/campylobacter-like organism (CLO) test, and polymerase chain reaction
(PCR). Urea breath test and stool (fecal) antigen tests are preferred for the
diagnosis of H. pylori infection and evaluate the effectiveness of treatment,
which is contributing to the dominance of the non-endoscopic segment.
On the basis of technology, the
global H. pylori test market has been divided into immunoassays, point-of-care
(POC), and molecular diagnostics. Molecular methods are widely used for the
diagnosis of H. pylori and to analyze diversity, virulence, and resistance
patterns of these bacteria. This has contributed to the segment’s
second-largest position in 2018.
By end-user, the market has
been bifurcated into hospitals and clinics, diagnostics laboratories, and
others. The hospitals and clinics segment would hold a substantial revenue
share during the assessment period attributed to facts that increase in the
number of H. pylori test procedures performed in these healthcare settings.
Key
Players
Some of the key players in the
Global H. Pylori Test Market are Thermo Fisher Scientific Inc. (US), Bio-Rad
Laboratories, Inc. (US), Quest Diagnostics Incorporated (US), F. Hoffmann-La
Roche Ltd (Switzerland), Meridian Bioscience (US), CorisBioconcept SPRL
(Belgium), Cardinal Health (US), Abbott Laboratories (US), QIAGEN (Germany),
and Biohit Oyj (Finland).
Browse Detailed TOC with
COVID-19 Impact Analysis at:
https://www.marketresearchfuture.com/reports/helicobacter-pylori-test-market-8497
About
Market Research Future:
At
Market Research Future (MRFR), we enable our customers to unravel the
complexity of various industries through our Cooked Research Report (CRR),
Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have
supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email:
sales@marketresearchfuture.com
Comments
Post a Comment